Dingemanse J, Hutson P H, Langemeijer M W, Curzon G, Danhof M
Center for Bio-Pharmaceutical Sciences, University of Leiden, The Netherlands.
Neuropharmacology. 1988 May;27(5):467-74. doi: 10.1016/0028-3908(88)90128-1.
As cerebrospinal fluid (CSF) possesses unique characteristics in order to explore concentration-pharmacological response relationships of drugs active in the CNS, the practicability of serial sampling of CSF was tested in a study with heptabarbital. Concentrations in CSF and plasma were measured simultaneously in individual rats during and after an intravenous infusion for 30 min. At the end of the infusion, the distribution equilibrium was attained with a CSF/plasma concentration ratio of 0.38, roughly equal to the fraction unbound to protein. When concentrations in blood and CSF were determined at the onset and offset of loss of righting reflex concentrations in blood were significantly greater at onset (146 +/- 19 mg/l) than at offset (108 +/- 16 mg/l, n = 6), whereas concentrations in CSF were identical (39 +/- 5 and 38 +/- 5 mg/l, respectively). This confirmed the earlier observation that the CSF is pharmacokinetically indistinguishable from the site of action. When the duration of the loss of righting reflex was varied, concentrations of heptabarbital in CSF at onset and offset were similar, independent of the duration of the loss of righting reflex (1-5 hr). These findings demonstrate the absence of the development of acute tolerance and confirmed that no (inter)active metabolites interfered with the pharmacological response. In a total number of 26 rats the concentrations in CSF at onset and offset of loss of the righting reflex were compared. The interindividual variation was 13-15% and the intra-individual variation was only 4-6%. The results demonstrate the usefulness of serial sampling of CSF in pharmacodynamic studies with centrally acting drugs.
由于脑脊液(CSF)具有独特的特性,为了探究作用于中枢神经系统(CNS)的药物的浓度-药理反应关系,在一项使用庚巴比妥的研究中测试了脑脊液连续采样的实用性。在对大鼠进行30分钟静脉输注期间及之后,同时测量个体大鼠脑脊液和血浆中的浓度。输注结束时,达到了分布平衡,脑脊液/血浆浓度比为0.38,大致等于未与蛋白质结合的部分。当在翻正反射消失的开始和结束时测定血液和脑脊液中的浓度时,血液中的浓度在开始时(146±19mg/L)显著高于结束时(108±16mg/L,n = 6),而脑脊液中的浓度相同(分别为39±5和38±5mg/L)。这证实了早期的观察结果,即脑脊液在药代动力学上与作用部位无法区分。当翻正反射消失的持续时间变化时,庚巴比妥在脑脊液开始和结束时的浓度相似,与翻正反射消失的持续时间(1 - 5小时)无关。这些发现表明不存在急性耐受性的发展,并证实没有(相互)活性代谢物干扰药理反应。在总共26只大鼠中,比较了翻正反射消失开始和结束时脑脊液中的浓度。个体间差异为13 - 15%,个体内差异仅为4 - 6%。结果表明脑脊液连续采样在中枢作用药物的药效学研究中是有用的。